Cargando…
Assessment of Early Tumor Response to Cytotoxic Chemotherapy with Dynamic Contrast-Enhanced Ultrasound in Human Breast Cancer Xenografts
There is a strong need to assess early tumor response to chemotherapy in order to avoid adverse effects from unnecessary chemotherapy and allow early transition to second-line therapy. This study was to quantify tumor perfusion changes with dynamic contrast-enhanced ultrasound (CEUS) in the evaluati...
Autores principales: | Wang, Jian-Wei, Zheng, Wei, Liu, Ji-Bin, Chen, Yao, Cao, Long-Hui, Luo, Rong-Zhen, Li, An-Hua, Zhou, Jian-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585723/ https://www.ncbi.nlm.nih.gov/pubmed/23469274 http://dx.doi.org/10.1371/journal.pone.0058274 |
Ejemplares similares
-
Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound
por: Chen, Yao, et al.
Publicado: (2015) -
Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound
por: Lin, Chun-yi, et al.
Publicado: (2013) -
Endoglin-targeted contrast-enhanced ultrasound imaging in hepatoblastoma xenografts
por: Shan, Rong, et al.
Publicado: (2018) -
Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound
por: Lamuraglia, Michele, et al.
Publicado: (2020) -
Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts
por: Cao, Long-Hui, et al.
Publicado: (2016)